Intercept Pharmaceuticals, Inc. announced the appointment of Jared M. Freedberg as General Counsel and Secretary. Mr. Freedberg joins the company from Immunomedics, Inc., which was acquired by Gilead Sciences in October of 2020. Freedberg was previously General Counsel and Secretary and a member of the Executive Leadership Team for Immunomedics, with responsibility for management of all legal activities, including compliance, securities, corporate and board governance, contracting, IP strategy and management, business development and litigation management.